BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

313 related articles for article (PubMed ID: 17270206)

  • 1. Clinicopathological relevance of tumour grading in canine osteosarcoma.
    Loukopoulos P; Robinson WF
    J Comp Pathol; 2007 Jan; 136(1):65-73. PubMed ID: 17270206
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical and pathologic relevance of p53 index in canine osseous tumors.
    Loukopoulos P; Thornton JR; Robinson WF
    Vet Pathol; 2003 May; 40(3):237-48. PubMed ID: 12724563
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of clinical and histopathologic prognostic factors for survival in canine osteosarcoma of the extracranial flat and irregular bones.
    Kruse MA; Holmes ES; Balko JA; Fernandez S; Brown DC; Goldschmidt MH
    Vet Pathol; 2013 Jul; 50(4):704-8. PubMed ID: 23269349
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glucose transporter 1 expression in canine osteosarcoma.
    Petty JC; Lana SE; Thamm DH; Charles JB; Bachand AM; Bush JM; Ehrhart EJ
    Vet Comp Oncol; 2008 Jun; 6(2):133-40. PubMed ID: 19178673
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Histologic prognosticators in feline osteosarcoma: a comparison with phenotypically similar canine osteosarcoma.
    Dimopoulou M; Kirpensteijn J; Moens H; Kik M
    Vet Surg; 2008 Jul; 37(5):466-71. PubMed ID: 18986314
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biological behaviour of canine mandibular osteosarcoma. A retrospective study of 50 cases (1999-2007).
    Coyle VJ; Rassnick KM; Borst LB; Rodriguez CO; Northrup NC; Fan TM; Garrett LD
    Vet Comp Oncol; 2015 Jun; 13(2):89-97. PubMed ID: 23410097
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of osteosarcoma cells from two sibling large-breed dogs.
    Norrdin RW; Powers BE; Torgersen JL; Smith RE; Withrow SJ
    Am J Vet Res; 1989 Nov; 50(11):1971-5. PubMed ID: 2619126
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diversity of Histologic Patterns and Expression of Cytoskeletal Proteins in Canine Skeletal Osteosarcoma.
    Nagamine E; Hirayama K; Matsuda K; Okamoto M; Ohmachi T; Kadosawa T; Taniyama H
    Vet Pathol; 2015 Sep; 52(5):977-84. PubMed ID: 25770040
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterisation of complex karyotype changes in two canine bone tumours.
    Mayr B; Eschborn U; Loupal G; Schleger W
    Res Vet Sci; 1991 Nov; 51(3):341-3. PubMed ID: 1780594
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Histological and immunohistochemical diversities, and proliferative activity and grading in osteosarcomas.
    Hasegawa T; Hirose T; Seki K; Hizawa K; Ishii S; Wakabayashi J
    Cancer Detect Prev; 1997; 21(3):280-7. PubMed ID: 9167046
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An in vivo/in vitro experimental model system for the study of human osteosarcoma: canine osteosarcoma cells (COS31) which retain osteoblastic and metastatic properties in nude mice.
    Shoieb AM; Hahn KA; Barnhill MA
    In Vivo; 1998; 12(5):463-72. PubMed ID: 9827352
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Production and characterization of canine osteosarcoma cell lines that induce transplantable tumors in nude mice.
    Nieves MA; Vahle J; Ackermann M; Howard M; Dietz AB; Carpenter SL; Cheville N
    Am J Vet Res; 1998 Mar; 59(3):359-62. PubMed ID: 9522958
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic significance of a new histologic grading system for canine osteosarcoma.
    Kirpensteijn J; Kik M; Rutteman GR; Teske E
    Vet Pathol; 2002 Mar; 39(2):240-6. PubMed ID: 12009062
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunohistochemical expression of COX-2, mPGES and EP2 receptor in normal and reactive canine bone and in canine osteosarcoma.
    Millanta F; Asproni P; Cancedda S; Vignoli M; Bacci B; Poli A
    J Comp Pathol; 2012; 147(2-3):153-60. PubMed ID: 22633646
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of DNA aneuploidy of primary and metastatic spontaneous canine osteosarcomas.
    Fox MH; Armstrong LW; Withrow SJ; Powers BE; LaRue SM; Straw RC; Gillette EL
    Cancer Res; 1990 Oct; 50(19):6176-8. PubMed ID: 2400984
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor necrosis following radiation therapy and/or chemotherapy for canine osteosarcoma.
    Withrow SJ; Powers BE; Straw RC; Thrall DE; Gillette EL; LaRue SM; Richter SL
    Chir Organi Mov; 1990; 75(1 Suppl):29-31. PubMed ID: 2249550
    [No Abstract]   [Full Text] [Related]  

  • 17. Oesophageal sarcomas in dogs: histological and clinical evaluation.
    Ranen E; Dank G; Lavy E; Perl S; Lahav D; Orgad U
    Vet J; 2008 Oct; 178(1):78-84. PubMed ID: 17804268
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Blood vessel density in canine osteosarcoma.
    Coomber BL; Denton J; Sylvestre A; Kruth S
    Can J Vet Res; 1998 Jul; 62(3):199-204. PubMed ID: 9684049
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Some prognostic and epidemiologic factors in canine osteosarcoma.
    Misdorp W; Hart AA
    J Natl Cancer Inst; 1979 Mar; 62(3):537-45. PubMed ID: 283283
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Primary versus radiation-associated craniofacial osteosarcoma: Biologic and clinicopathologic comparisons.
    McHugh JB; Thomas DG; Herman JM; Ray ME; Baker LH; Adsay NV; Rabah R; Lucas DR
    Cancer; 2006 Aug; 107(3):554-62. PubMed ID: 16795069
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.